Summary Spontaneously transformed somatic thyrocyte mutants, FRTL-5/TA and FRTL-5/TP, are thyrotropin (TSH) independent for growth and show loss of the thyroid-specific phenotype, with absent thyroglobulin and thyroid peroxidase gene expression. To investigate the role of TSH-receptor (TSH-R) activation in rat thyroid growth and function, binding of TSH and TSH-induced cAMP production were measured in intact cells under identical assay conditions. TSH binding did not differ in terms of affinity and receptor number and presence of 5.6 kb and 3.3 kb mRNA rat TSH-R transcripts was determined in all variants. By contrast, basal cAMP was I1-fold lower in FRTL-5/TA and 6-fold lower in FRTL-5/TP than in wild-type FRTL-5 (1.1+0.4; P<0.01). Maximal cAMP production was similar between wild-type and cell variants and stimulation by bovine, rat and recombinant human TSH revealed normal activation patterns. Therefore, a dissociation was present between the loss of TSH control on growth and function, and the presence of a normally functioning TSH-R. Subsequent to TSH incubation FRTL-5/TP and FRTL-5/TA cells showed a different expression pattern of TSH-R and the proto oncogenes c-myc and fos than FRTL-5 wildtype. The data indicated that the cause of the TSH-independency is located down-stream of the cAMP cascade, influencing genes that control the expression of cell cycle-related proto-oncogenes and thyroid-specific genes.
The glycoprotein hormone thyrotropin (TSH) is the major regulator of thyroid function and growth . Actions of TSH are exerted through interaction with the plasma membrane TSH receptor (TSH-R), which has been characterised as a member of the Gprotein coupled receptor family (Nagayama et al., 1989; Libert et al., 1989) . Following binding of TSH to the TSH-R, G-proteins will be activated, resulting in stimulation of adenylate cyclase and cAMP production or in stimulation of phospholipase C with subsequent diacylglycerol and inositol-3-phosphate production . cAMP is generally assumed to regulate a major part of thyroid function and thyroid growth .
Thyroid tumours can be divided into functional and nonfunctional tumours. With regard to growth and metabolic activity, functional tumours are responsive to TSH like normal thyroid tissue. As a tumour evolves, phenotypespecific metabolic activities decrease or disappear (Christov and Raichev, 1972; Wollman, 1963) , as has been described in transgenic models (Ledent et al., 1991) . Non-functional tumours show absence of phenotype-specific thyroid functions and, characteristically, TSH is unable to stimulate such functions, or growth. Therefore, loss of TSH responsiveness could result from a TSH-R defect or a defect in a postreceptor element important for signal transduction. For example, absence of high-affinity TSH-R (Abe et al., 1981) , a defective coupling between the TSH-R and G-protein (Namba et al., 1993) , a TSH-R point mutation (Parma et al., 1993) , and a Gsa mutation including those found in other endocrine tumours (Lyons et al., 1990; Yoshimoto et al., 1993) have been suggested to explain the observed TSH independency or TSH unresponsiveness. In experimental terms validity of either of the first two possibilities would be supported by findings of abnormal TSH binding or an abnormal pattern of TSH-induced cAMP production. The latter two possibilities are then expected to result in a higher basal cAMP level.
In the present study we tested these possibilities experimentally using the FRTL-5 rat thyroid cell line and spontaneously transformed somatic cell variants with different degrees of differentiation and sensitivity to TSH (Ossendorp et al., 1990) . FRTL-5 cells are an accepted model for normal thyroid function as these cells show responsiveness to TSH for iodide uptake, thyroglobulin (Tg) iodination and secretion, and cell growth. The variant cell lines have been generated by subcutaneous injection of FRTL-5 cells in nude mice. From the tumours that subsequently developed, variant cell lines were derived as described by Ossendorp et al. (1990) . The variant cell line FRTL-5/T, isolated from a functionally active tumour, shows normal responsiveness to TSH for most thyroid-specific functions (Ossendorp et al., 1990) . This is in contrast to the FRTL-5/TA and FRTL-5/TP variants, isolated from non-functional tumours, which are insensitive to TSH with respect to iodide uptake, thyroglobulin iodination and secretion, and cell growth, thus fulfilling the criteria of somatic cell mutants with the phenotype of autonomous TSH-independent growth and function (Ossendorp et al., 1990) . In the present study we evaluated whether acquisition of autonomy was associated with defects in the binding of the ligand, or with defects in the second messenger system. The production of cAMP in response to TSH was characterised under the same conditions in which TSH binding to its receptor can be measured; binding was evaluated in terms of capacity and affinity. In addition, the response of the proto-oncogenes c-myc and fos was measured to characterise the effect of TSH at the early steps of the cell cycle.
(Gibco BRL, Breda, The Netherlands) containing 5% fetal calf serum (Gibco) and insulin (10 jug ml-'), hydrocortisone (0.36 ng ml-'), transferrin (5 jug ml-1), somatostatin (10 ng ml-'), glycyl-L-histidyl-L-lysine acetate (2 ng ml-') (all Sigma, St Louis, MO, USA) and bTSH (bovine TSH) 100 uU ml-1 (Ambinon, Organon, Oss, The Netherlands). As FRTL-5/TA cells were generated under TSH-free conditions, the cells were cultured in SH (5 hormone mixture) medium (TSH-free medium, identical to the medium described above but without TSH) as described previously (Ossendorp et al., 1990) .
In experiments that measured cAMP production and TSH binding, cells were cultured in six-well plates (Gibco (Van Zoelen, 1989) . To compare the affinities of bTSH, rTSH and rhTSH IC50-values (50% competition) were determined from the competition curves.
Effect of TSH on intracellular cAMP response Confluent cells were washed three times with HBSS. The cells were incubated at 37°C in 1 ml of HBSS containing 0.5 mM 3-isobutyl-l-methylxanthine (Sigma) and various concentrations of bTSH, rhTSH, rTSH (0-0.24, 0-0.44 and 0-0.024 UM respectively). After 1 h the incubation was terminated by removing the buffer and addition of 1 ml of 96% ice-cold ethanol. Cells were stored at least overnight at -20°C. Cells were scraped with a rubber policeman, the ethanol was evaporated at 37°C under a stream of nitrogen and 0.5 ml of a Tris-EDTA (50 mm, 4 mM, pH 7.5) buffer was added. After centrifugation for 10 min at 3600 r.p.m. the supernatants were used to measure cAMP (radioreceptor assay TRK 432, Amersham, Little Chalfont, UK). DNA was measured in the pellets (Burton, 1956), using calf thymus DNA (Boehringer analysis is only reported for the one class model (Table I) . Neither the KS (1.0-2.4 nM) nor the receptor number (R) differed significantly among the different cell lines. Competition by TSH from several species (rat, bovine and recombinant human) showed a similar pattern between cell variants (Figure 1) . Differences between TSH species were noted, i.e. the IC50 value of rhTSH was approximately one order of magnitude higher than the IC50 value of bTSH and rTSH, by contrast the IC50 value of rTSH did not differ from IC50 found with bTSH (Table I) .
Measurement of cAMP response to TSH (Figure 1 , Table II) The basal intracellular cAMP level was 1 1-fold lower in FRTL-5/TA cells and 5.8-fold lower in FRTL-5/TP cells than in wild-type FRTL-5 (1.1 +0.35 pmol cAMP ,ug`DNA). In contrast a cAMP response was elicited by TSH to the same maximal level in each cell variant (7.9 -1 1.1 pmol cAMP ig'-l DNA) by 240 nM. Thus, the induction of cAMP production by TSH is different between wild-type (10-fold induction) and the TSH-independent growing cell lines FRTL-5/TP and FRTL-5/TA (64-to 79-fold induction). Similar EC50 values were obtained with rTSH and bTSH. The EC50 value of rhTSH was approximately one order of magnitude higher than the EC50 value of bTSH and rTSH. The significant differences between rhTSH IC50 and EC50 values, observed in the variant cell lines, was probably caused by the use of two different batches of rhTSH. Different batches of rhTSH have different degrees of sialylation and sulphation, causing different TSH bioactivity (Szkudlinski et al., 1993) .
Northern blotting (Figure 3) The rat TSH-R-specific probe hybridised with a 5.6 and 3.3 kb mRNA signal respectively, following Northern blotting. These sizes of mRNA transcripts have been identified in FRTL-5 cells as transcripts of the rat TSH-R (Akamizu et al., 1990) . In all variants normal sized TSH-R mRNA transcripts were observed (Figure 3 sites per cells (± 1.1 x 106), we concluded that this class of low-affinity binding sites represents non-specific binding. This is in agreement with other reports (Chazenbalk et al., 1990; Nagayama and Rapoport, 1992) , which concluded that this class of binding sites is an artefact because both untransfected and TSH-R transfected CHO cells show the same lowaffinity site. The FRTL-5/TP and FRTL-5/TA variants showed normal maximal cAMP response, but 6-to 11-fold lower basal intracellular cAMP concentrations than wild-type FRTL-5. The EC50 values obtained with rat and bovine TSH were similar between all variants and wild-type FRTL-5. Assays of TSH binding and TSH-induced cAMP production were carried out under identical conditions of cell culture, excluding artefacts which might be caused by low-salt and high-salt culture conditions ). The present findings therefore formally demonstrate the dissociation between presence of a functionally intact TSH-R, able to activate the cAMP cascade and TSH control on the growth and differentiation in FRTL-5/TP and FRTL-5/ TA cells.
The exact role of TSH in the control of thyroid growth is still unresolved because thyroid mitogenic and anti-mitogenic effects have been reported in different species (Maenhaut et al., 1990; Vassart and Dumont, 1992) . TSH is a proven growth factor in FRTL-5 cells (Jin et al., 1986; Coletta et al., 1986) , dog thyrocytes (Maenhaut et al., 1990 ) and human thyrocytes . TSH is able to activate both the cAMP cascade and phospholipase C pathway independently by binding to its receptor (Maenhaut et al., 1990; Fujimoto and Brenner-Gatti, 1992) . The current theory is that enhancement of the cAMP cascade relates to stimulation and control of functional characteristics in human and FRTL-5 (rat) thyrocytes, including iodide uptake and expression of thyroid-specific proteins thyroglobulin and thyroid peroxidase (Maenhaut et al., 1990) . In agreement with this theory is the recent demonstration that gain-of-function mutations in the TSH-R cause hyperfunctioning thyroid adenomas (Parma et al., 1993) and congenital hyperthyroidism (Kopp et al., 1995) , which are characterised by higher basal intracellular cAMP concentrations in agreement with the original report by Kasagi et al. (1980) in a collection of human adenoma tissues. Dedifferentiating tumours may then be caused by activation of growth factor and phorbol ester cascades (Maenhaut et al., 1990; Mockel et al., 1994) , and not through activation of cAMP cascade. The finding of reduced basal cAMP concentrations in dedifferentiated FRTL-5/TP and FRTL-5/TA cells, a factor 6 to 11 lower than FRTL-5 cells, therefore represents novel evidence to support this theory, and possibly indicates a mechanism of inverse agonism, causing a reduction in the basal regulation of the adenylate cyclase (Milligan et al., 1995) . FRTL-5/TA and FRTL-5/TP cells have lost most of the thyroid-specific phenotype of wild-type FRTL-5 cells as demonstrated by virtual absence of iodide uptake, and absence of thyroglobulin and TPO mRNA (Ossendorp et al., 1990) . In addition, FRTL-5/TP and FRTL-5/TA cells demonstrate a dissociation between intact TSH-R function in the cAMP cascade and loss of TSH control over thyroid growth. Thus, acquisition of dominant signal transduction pathways other than the cAMP cascade, or in theory further downstream in the cAMP cascade, is relevant and advantageous for thyrocytes to develop autonomous growth and dedifferentiation.
The present findings do not support the claim by Berlingeri et al. (1990) that the loss of TSH control on growth correlates with the complete loss of rat TSH-R gene expression. Using the same rat TSH receptor cDNA probe, these authors could not detect TSH-R mRNA in oncogene transformed FRTL-5 cells; functional TSH binding was not measured. We detected TSH-R mRNA in TSH-independent FRTL-5/TP and FRTL-5/TA variants, although the gene expression was lower than the corresponding transcript signal in FRTL-5 cells. Interestingly, this reduction in TSH-R gene expression did not affect the binding characteristics of radiolabelled TSH. The present data indicated that TSH-R mRNA does not correspond to the number of functioning receptors, suggesting: (1) that degradation or stability of mRNA species (5.6 and 3.3 kb) is different between cell variants; (2) TSH-R protein may have a larger residence time on the cell surface; and (3) a functional assay of TSH binding needs to be combined with measurement mRNA TSH-R levels. In the literature, species-specific responses of TSH-R mRNA expression to TSH exposure have been reported: down-regulation in rat thyrocytes (Akamizu et al., 1990 ; and the present findings), a slight down-regulation in dog thyrocytes and no marked down-regulation in human thyrocytes . Significantly reduced TSH-R gene expression has also been found in neoplastic human thyroid tissues in conjunction with reduced thyroglobulin gene expression (Ohta et al., 1990; Elisei et al., 1994) . However, several laboratories have shown that functional TSH binding is, in general, not different between normal and neoplastic human thyroid tissues (Karlsson and Dahlberg, 1979; Matsuo et al., 1993 Civitareale et al., 1993; Shimura et al., 1994) . Interestingly, transformation of FRTL-5 cells with viral oncogenes (Ki-ras, Ha-ras and mos) leads to undetectable expression of Tg and TPO genes (as in the FRTL-5/TP and FRTL-5/TA variants), in combination with absence of Pax-8 expression . Further studies are planned to characterise the dominant signal transduction pathways in FRTL-5/TP and FRTL-5/ TA cells and their effect on genes known to be involved in thyroid growth and function. In conclusion, a functionally normal TSH-R was found in FRTL-5 cells and its TSHindependent variants. Mutations in the TSH-R or G,a are therefore unlikely explanations for the TSH independence in FRTL-5/TP and FRTL-5/TA cells. In these cells the functionally intact TSH-R is dissociated from the TSH control on growth and differentiation. Supported by the reduced basal levels of cAMP in FRTL-5/TP (6-fold) and FRTL-5/TA (11-fold), we conclude that a different mechanism, down-stream of the cAMP cascade, is responsible for a different activation pattern offos, c-myc and TSH-R mRNA and the autonomous growth of FRTL-5/TP and FRTL-5/TA cells.
